Kathleen Tregoning
Directeur/Membre du Conseil chez SPERO THERAPEUTICS, INC.
Fortune : 470 169 $ au 30/04/2024
Profil
Kathleen Tregoning is currently an Independent Director at Spero Therapeutics, Inc. since 2021 and the Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc. since 2020.
Previously, she served as the Executive Vice President-External Affairs at Sanofi from 2017 to 2020.
She also held the position of Senior Vice President-Corporate Affairs at Biogen France SAS.
Ms. Tregoning completed her undergraduate degree at Stanford University and her graduate degree at Harvard Kennedy School of Government.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/01/2024 | 10 666 ( 0,01% ) | 448 719 $ | 30/04/2024 | |
SPERO THERAPEUTICS, INC.
0,03% | 01/04/2024 | 15 000 ( 0,03% ) | 21 450 $ | 30/04/2024 |
Postes actifs de Kathleen Tregoning
| Sociétés | Poste | Début |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Public Communications Contact | 01/07/2020 |
| SPERO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/10/2021 |
Anciens postes connus de Kathleen Tregoning
| Sociétés | Poste | Fin |
|---|---|---|
| SANOFI | Public Communications Contact | 01/03/2020 |
Biogen France SAS
 Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Formation de Kathleen Tregoning
| Stanford University | Undergraduate Degree |
| Harvard Kennedy School of Government | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANOFI | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Health Technology |
